Journal of Virology · 1996 · 42 citations · 23 references
Life SciencesMolecular BiologyOncologyCancer GeneticsMolecular OncologyOncogenesLymphoid NeoplasmsMajor Histocompatibility ComplexMyc Family OncogenesOncogenic VirusesT Cell Responses To TumorsViral OncogenesOncogenic RetrovirusesProviral IntegrationRetroviral OncogenesRetrovirus BiologyRetrovirus GenomicsT-cell Receptor Beta Chain GeneticsViral Genome Integration SitesViral Integration Sites
The murine retrovirus SL3-3 is a potent inducer of T-cell lymphomas when inoculated into susceptible newborn mice. The proviral integration site sequences were surveyed in tumor DNAs by a simple two-step PCR method. From 20 SL3-3-induced tumors a total of 39 provirus-host junctions were amplified and sequenced. Seven showed homology to known sequences. These included the known common integration site c-myc as well as genes not previously identified as targets of provirus integration, namely N-ras and the genes coding for major histocompatibility complex class 11 E-beta, protein kinase C-eta, and T-cell receptor beta-chain. Among these genes, the integrations in c-myc as well as the one in N-ras were found to be clonal. One of the remaining 32 proviral integration site sequences that show no similarities to known sequences may represent a common integration site, as 2 of the 20 tumors demonstrated clonal provirus insertion into this region.
23
Shin‐Ichi Osada, Keiko Mizuno, Takaomi C. Saido et al. · Journal of Biological Chemistry · 1990 · 428 citations · Full text
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion
Lynn M. Corcoran, Jerry M. Adams, Ashley R. Dunn et al. · Cell · 1984 · 358 citations · Full text
Medicine, Cancer Biology, Oncology +16